UK biotech Amryt has secured itself access to a novel gene therapy platform that could give rise to a new treatment option for patients with Epidermolysis bullosa (EB), a group of rare inherited skin disorders that cause the skin to become very fragile.
16th March 2018
Alexion is gearing up to file its experimental therapy for paroxysmal nocturnal hemoglobinuria (PNH) with regulators on both sides of the Altantic following the success of a late-stage clinical trial.
16th March 2018
MSD’s Keytruda is the first and only immunotherapy to be recommended for NHS use to treat urothelial carcinoma patients, when prior platinum-containing chemotherapy fails.
16th March 2018
Researchers are calling for a government investigation into the “substantial increase” in mortality seen in early 2018 in England and Wales.
15th March 2018
More women in England and Wales are to be offered a test to better determine the causes of heavy menstrual bleeding, on updated guidelines from the National Institute for Health and Care Excellence.
15th March 2018
According to NHS England more than half of patients routinely attending sessions offered as part of its diabetes prevention programme have achieved weight losss equivalent to nearly 15 double cheeseburgers.
15th March 2018
BenevolentAI has teamed up with Action Against AMD* to find treatments and a potential cure for age-related macular degeneration, the leading cause of blindness in the UK.
15th March 2018
Chancellor Philip Hammond boosted growth projections and forecast falling inflation for the UK in his Spring Statement, but health care leaders lamented his lack of action on addressing the NHS crisis.
14th March 2018
GP leaders are reiterating their call for longer consultation times on the back of a new analysis showing that patients with multi-morbidities account for more than half of appointments.
14th March 2018
Cancer Research UK is partnering with US biotech Ideaya Biosciences to develop small molecule inhibitors of Poly(ADP-ribose) glycohydrolase (PARG).
14th March 2018
US regulators will undertake a priority review of MSD’s Keytruda as a treatment for patients with advanced cervical cancer.
14th March 2018
A second late-stage study assessing AbbVie and Neurocrine’s experimental drug elagolix in women with uterine fibroids has met its primary endpoint.
14th March 2018
Scientists have uncovered a novel approach to fighting hard-to-treat breast cancers, triggering a new drug programme designed to develop novel targeted therapies for the disease.
13th March 2018
US regulators have placed on hold a clinical trial testing a combination of Advaxis’ axalimogene filolisbac and AstraZeneca's Imfinzi after a patient died from respiratory failure.
13th March 2018
The Scottish Medicines Consortium (SMC has published new guidelines approving NHS funding for medicines for breast cancer and Hodgkin’s lymphoma.
13th March 2018
